Nutriband (NASDAQ: NTRB) — Perfil da empresa, notícias e dados financeiros
Nutriband is a pharmaceutical company specializing in transdermal drug delivery technologies to enhance patient care.
Nutriband
Nutriband (NASDAQ:NTRB) specializes in the development of innovative pharmaceutical and health product technologies, primarily focusing on the application of transdermal and topical delivery systems. The company is dedicated to improving the efficiency and convenience of drug delivery through these cutting-edge methods. Nutriband's projects span across a range of health concerns, aiming to address both common and niche medical needs. With a strong commitment to research and development, Nutriband seeks to continually expand its product portfolio, striving to improve patient outcomes and adherence to medication regimes. The primary objective of Nutriband is to become a key player in the transdermal and topical drug delivery market, enhancing healthcare experiences for patients worldwide.
Resumo
Operações
Produtos e/ou serviços de Nutriband
- Transdermal patches for delivering medications across the skin, offering a painless alternative to injections.
- Development of abuse-deterrent patch technologies aimed at combating opioid misuse by preventing non-intended forms of delivery.
- A line of health and fitness supplements designed to support various aspects of wellness and performance.
- Patches for motion sickness, providing relief from nausea and vomiting associated with travel.
- Nutritional patches, offering a novel way to absorb vitamins and minerals through the skin.
- Technology for enhancing the bioavailability of active pharmaceutical ingredients, improving the efficiency of drug delivery systems.
equipe executiva do Nutriband
- Serguei MelnikFounder, President, Company Secretary & Executive Chairman
- Gareth SheridanFounder, CEO & Director
- Gerald GoodmanCFO & Chief Accounting Officer
- Alan SmithCOO & President of 4P Therapeutics
- Jeffrey PatrickChief Scientific Officer
- Michael MyerPresident of Pocono Pharmaceutical
- Tyler OverkHead of Active Intelligence
Principais indicadores financeiros
Resultados divulgados pela Nutriband, em USD.
- Cap. de mercado
- 77,8 mi
- Receita (TTM)
- 1,6 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.5
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 2 mi | -8,3 mi | -8,2 mi | |
| 2,1 mi | -6,7 mi | -10,5 mi | |
| 2,1 mi | -4,9 mi | -5,5 mi | |
| 2,1 mi | -4,1 mi | -4,8 mi |